Ketogia Tablet contains Alpha Ketoanalogue (NA), a specialized compound used primarily as a dietary supplement in the management of chronic kidney disease (CKD). Alpha Ketoanalogue serves as a nitrogen-free analogue of essential amino acids, aiding in the reduction of nitrogenous waste accumulation in patients with impaired renal function. By providing the necessary substrates for protein synthesis without increasing nitrogen load, Ketogia Tablet helps to mitigate the progression of uremia and delays the onset of dialysis in CKD patients. It is typically administered alongside a low-protein diet to optimize metabolic balance and preserve residual kidney function. The tablet is indicated for individuals with moderate to severe renal insufficiency who require nutritional support to maintain adequate protein metabolism while minimizing nitrogenous waste production. Ketogia is generally well tolerated, but should be used under medical supervision, especially in patients with altered electrolyte levels or metabolic imbalances. Regular monitoring of renal parameters and nutritional status is recommended during therapy. Ketogia Tablet is contraindicated in patients with hypersensitivity to any component of the formulation and should be used cautiously in those with hepatic impairment. Its use contributes to improved clinical outcomes by supporting nutritional status and reducing the burden on compromised renal function.